Endnotes and References The efficacy estimand represents efficacy had all randomized participants remained on study intervention (with possible dose interruptions and/or dose modifications) for 52 weeks without initiating prohibited weight management treatments, and assuming participants who took rescue orforglipron would not have received any additional improvement from their randomized study treatment
But the $500-a-month bill made the drug unaffordable
While comprehensive interaction data is limited, certain combinations have established usage patterns
Glucagon Suppression Extensive Research Pramlintide suppresses the inappropriate postprandial glucagon secretion that is a hallmark of both type 1 and type 2 diabetes, addressing a pathophysiological defect that is not corrected by insulin therapy alone
1 Figure 1: GLP-1 trends since 2019, created using data from FAIR Health study
Daily totals: 104 grams protein, 28 grams fiber, 1,240 calories